Our products
Our patented enzyme-based technologies originate from high-quality natural raw materials, ensuring scientifically validated efficacy and a true competitive advantage across multiple health targets.
Patented technology for producing enzymatic hydrolysates rich in bioactive peptides with the ability to inhibit angiotensin-converting enzyme (ACE). Through an optimized enzymatic hydrolysis process, this innovation enables the development of functional ingredients for use in dietary supplements, functional foods, and other health-focused applications aimed at supporting blood pressure management and cardiovascular health.
Patented technology based on protein hydrolysates and bioactive peptides obtained through innovative enzymatic processes. The invention modulates the incretin system by inhibiting the DPP-IV enzyme and enhancing GLP-1 secretion, providing a natural solution for the development of dietary supplements, functional foods, and therapeutic applications aimed at supporting the prevention and management of type 2 diabetes, hyperglycemia, overweight, and obesity.
Patented technology based on a bioactive composition designed to modulate leptin levels and support healthy blood pressure regulation. This innovation is intended for the development of dietary supplements, functional foods, and other science-driven health solutions targeting overweight, obesity, and hypertension, contributing to improved metabolic and cardiovascular health.
